Search results
3 lis 2020 · We aimed to assess contralateral breast cancer (CBC) risk in patients with ductal carcinoma in situ (DCIS) compared with invasive breast cancer (BC).
- The risk of contralateral breast cancer: a SEER-based analysis - Nature
cancer. RESULTS: There were 25,958 cases of contralateral...
- Contralateral breast cancer risk in patients with ductal ... - Nature
We aimed to assess contralateral breast cancer (CBC) risk in...
- The risk of contralateral breast cancer: a SEER-based analysis - Nature
cancer. RESULTS: There were 25,958 cases of contralateral invasive breast cancer diagnosed (3.2% of all patients). The annual risk of contralateral breast cancer over the 25-year...
17 lut 2021 · Estimates of contralateral breast cancer (CBC) risk in the modern treatment era by year of diagnosis and characteristics of the first breast cancer are needed to assess the impact of recent advances in breast cancer treatment and inform clinical decision making.
We aimed to assess contralateral breast cancer (CBC) risk in patients with ductal carcinoma in situ (DCIS) compared with invasive breast cancer (BC).
21 paź 2022 · Contralateral breast cancer (CBC) is the most common second primary cancer among women diagnosed with first primary invasive breast cancer (BC) [1]. CBC accounts for approximately 40–50% of all new secondary cancers in women with first primary invasive BC and has a potentially less favorable prognosis [2, 3, 4, 5, 6].
17 gru 2019 · Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the consequent burden of further treatment and potentially less favorable prognosis. We aimed to develop and validate a CBC risk prediction model and evaluate its applicability for clinical decision-making.
Risk of contralateral breast and other cancers in patients with invasive lobular breast cancer. Background: Women with early-stage breast cancer (BCa) are living longer, and survivorship issues in-cluding second primary cancers (SPCs) are therefore increasingly important.
